License and Collaboration Agreements - Additional Information (Details) - Collaborative Arrangement [Member] - SIIPL [Member]	1 Months Ended
	Mar. 31, 2022 USD ($) Product
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
License agreement date	2022-03
Initial license agreement for number of products | Product	3
Option to increase license agreement for number of products | Product	2
Option to purchase developed research plan and clinical trial data for percentage of actual cost	50.00%
Upfront license fee to be received	$ 5,000,000.0
Collaborative arrangement aggregate milestone receivable	22,000,000.0
Maximum manufacturing technology transfer payments to be received	$ 10,000,000.0